Cardiac arrhythmias in patients with asthma-copd associated pathology
DOI:
https://doi.org/10.15587/2519-4798.2017.113513Keywords:
associated pathology of bronchial asthma and COPD, arrhythmia, heart rate variabilityAbstract
The aim of the study was to reveal features of cardiac arrhythmias in patients with the associated pathology of bronchial asthma and COPD, estimation of co-morbid cardiovascular diseases and the cardiovascular risk degree.
Materials and methods. The study included patients with the associated of asthma and COPD and also patients with bronchial asthma and COPD without association signs. All patients underwent: the general clinical examination, spirometry, Holter ECG monitoring, echocardiography and determination of the speed of pulse wave distribution.
Results. According to the data of day ECG monitoring, there was revealed the high frequency of arrhythmias registration in patients with bronchial obstructive diseases, especially often, ventricular and supraventricular arrhythmias were detected in patients with COPD and ACCS. The analysis of heart rate variability revealed statistically lower temporal indices in patients with COPD and ACCS comparing with ones in patients with BA. Even more negative changes of these heart rate and variability indices were revealed in patients with ACCS with the high level of bronchial obstruction, at expressed symptoms of the main disease and at the concomitant cardiovascular pathology.
Patients with ACCS demonstrated essential statistically reliable connections between indices of heart rate variability and hemodynamic parameters.
Conclusions. Patients with COPD and associated bronchial obstructive pathology demonstrated more expressed changes of heart rate variability indices compared with patients with BA. More expressed negative changes of the heart rate variability were detected in patients with ACCS with the high level of symptoms and bronchial obstruction
References
- Feschenko, Yu. I. (2015). Bronhialna astma, hronichne obstruktivne zahvoryuvannya legen: perspektivna globalna strategiya vedennya, novitni metodi diagnostiki, suchasni pidhodi do terapiyi. Astma ta alergiya, 4, 38–42.
- Yachnyk, A., Svintsitskyi, A., Shuper, S. (2014). Khronichne obstruktyvne zakhvoriuvannia lehen ta ishemichna khvoroba sertsia: paraleli i perekhrestia komorbidnosti. Ukrainskyi pulmonolohichnyi zhurnal, 4, 38–42.
- Mostovoi, Yu. M. (2011). Bronkhialna astma, KhOZL ta sertsevo-sudynnizakhvoriuvannia. Zdorovia Ukrainy, 3 (256), 30–31.
- Hillas, G., Perlikos, F., Tsiligianni, I., Tzanakis, N. (2015). Managing comorbidities in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 10, 95–109. doi: 10.2147/copd.s54473
- Hines, K. L., Peebles, R. S. (2017). Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence. Current Allergy and Asthma Reports, 17 (3), 15. doi: 10.1007/s11882-017-0683-4
- Global Strategy for the Diagnosis, Management and Prevention of COPD (2017). GOLD. Available at: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/
- Barnes, P. J., Burney, P. G. J., Silverman, E. K., Celli, B. R., Vestbo, J., Wedzicha, J. A., Wouters, E. F. M. (2015). Chronic obstructive pulmonary disease. Nature Reviews Disease Primers, 1, 150–176. doi: 10.1038/nrdp.2015.76
- Campo, G., Pavasini, R., Malagu, M., Mascetti, S., Biscaglia, S., Ceconi, C. et. al. (2015). Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management. Cardiovascular Drugs and Therapy, 29 (2), 147–157. doi: 10.1007/s10557-014-6569-y
- De Miguel-Diez, J., Chancafe Morgan, J., Jimenez-Garcia, R. (2013). The association between COPD and heart failure risk: a review. International Journal of Chronic Obstructive Pulmonary Disease, 8, 305–312. doi: 10.2147/copd.s31236
- Divo, M., Cote, C., de Torres, J. P., Casanova, C., Marin, J. M. et. al. (2012). Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 186 (2), 155–161. doi: 10.1164/rccm.201201-0034oc
- Xu, M., Xu, J., Yang, X. (2017). Asthma and Risk of Cardiovascular Disease or All-Cause Mortality: A Meta-Analysis. Annals of Saudi Medicine, 37 (2), 99–105. doi: 10.5144/0256-4947.2017.99
- Wang, L., Gao, S., Yu, M., Sheng, Z., Tan, W. (2017). Association of asthma with coronary heart disease: A meta analysis of 11 trials. PLOS ONE, 12 (6), e0179335. doi: 10.1371/journal.pone.0179335
- Yeh, J.-J., Wei, Y.-F., Lin, C.-L., Hsu, W.-H. (2017). Association of asthma–chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study. BMJ Open, 7 (10), e017657. doi: 10.1136/bmjopen-2017-017657
- Ebi-Kryston, K. L., Hawthorne, V. M., Rose, G., Shipley, M. J., Gillis, C. R., Hole, D. J. et. al. (1989). Breathlessness, Chronic Bronchitis and Reduced Pulmonary Function as Predictors of Cardiovascular Disease Mortality among Men in England, Scotland and the United States. International Journal of Epidemiology, 18 (1), 84–88. doi: 10.1093/ije/18.1.84
- Yanbaeva, D. G., Dentener, M. A., Creutzberg, E. C., Wesseling, G., Wouters, E. F. M. (2007). Systemic Effects of Smoking. Chest, 131 (5), 1557–1566. doi: 10.1378/chest.06-2179
- Rusinowicz, T., Zielonka, T. M., Zycinska, K. (2017). Cardiac Arrhythmias in Patients with Exacerbation of COPD. Advances in Experimental Medicine and Biology, 1–10. doi: 10.1007/5584_2017_41
- Warnier, M. J., Rutten, F. H., Kors, J. A., Lammers, J. W. J., de Boer, A., Hoes, A. W., de Bruin, M. L. (2012). Cardiac Arrhythmias in Adult Patients with Asthma. Journal of Asthma, 49 (9), 942–946. doi: 10.3109/02770903.2012.724132
- Global initiative for asthma (2016). Available at: http://ginasthma.org/
- Lapach, S. N., Chubenko, A. B., Babich, P. N. (2000). Statisticheskie metodyiv mediko–biologicheskih issledovaniyah s ispolzovaniem Excel. Kyiv: Morion, 320.
- Thayer, J. F., Yamamoto, S. S., Brosschot, J. F. (2010). The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. International Journal of Cardiology, 141 (2), 122–131. doi: 10.1016/j.ijcard.2009.09.543
- Hillebrand, S., Gast, K. B., de Mutsert, R., Swenne, C. A., Jukema, J. W., Middeldorp, S. et. al. (2013). Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose–response meta-regression. EP Europace, 15 (5), 742–749. doi: 10.1093/europace/eus341
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Ksenia Nazarenko
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.